Stay updated on Pembrolizumab for Refractory Esophageal Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab for Refractory Esophageal Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab for Refractory Esophageal Cancer Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    7 days ago
    Change Detected
    Summary
    The revision tag on the page was updated from v3.6.5 to v3.6.6, indicating a newer version of the site’s interface. This is an internal version change and does not imply changes to the study data or eligibility information.
    Difference
    0.1%
    Check dated 2026-08-30T22:23:19.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    No Change Detected
  5. Check
    29 days ago
    Change Detected
    Summary
    Updated page revision tag from v3.6.4 to v3.6.5, indicating a minor maintenance update. The visible content and structure of the page remain unchanged.
    Difference
    0.1%
    Check dated 2026-08-09T09:14:09.000Z thumbnail image
  6. Check
    44 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.6.4, replacing Revision: v3.6.3. This reflects a routine page update and does not alter the study information.
    Difference
    0.1%
    Check dated 2026-07-25T18:24:46.000Z thumbnail image
  7. Check
    65 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.6.3, replacing Revision: v3.6.2 as part of a minor revision to the page's revision history.
    Difference
    0.1%
    Check dated 2026-07-04T10:07:31.000Z thumbnail image
  8. Check
    72 days ago
    Change Detected
    Summary
    The page revision label was updated from v3.6.0 to v3.6.2. This reflects a minor system/UI update rather than changes to the study details.
    Difference
    0.1%
    Check dated 2026-06-27T05:43:12.000Z thumbnail image
  9. Check
    86 days ago
    Change Detected
    Summary
    The page now indicates that recruitment is closed, and several help/navigation items were added while two formatting/version notes were removed or updated.
    Difference
    0.4%
    Check dated 2026-06-13T01:32:58.000Z thumbnail image

Stay in the know with updates to Pembrolizumab for Refractory Esophageal Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for Refractory Esophageal Cancer Clinical Trial page.